The European Patent Office (EPO) has granted patent EP3039131B1, titled 'Enzyme Composition and Uses Thereof,' effective March 18, 2026. This patent covers specific enzyme compositions and their applications, falling under various International Patent Classification (IPC) codes related to enzymes and biochemical processes. The designated states include a broad range of European countries.

This patent grant signifies a new intellectual property right for the inventors and their associated entities. Companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in enzyme development or utilization, should review the patent details to ensure their activities do not infringe upon this granted right. No immediate compliance actions are required for entities outside of those directly involved in the patented technology, but awareness of the IP landscape is advised.